Diabetes lures pharma to the Gulf

Share this article:

Diabetes is a growing problem and pharmaceutical opportunity in Saudi Arabia. The Wall Street Journal outlines the health crisis that is increasingly visible during mall walks that double as a respite from the heat and a time to mingle over fast food.

The Journal also notes that governments in the Gulf have offered a mix of financial incentives to coax businesses to take manufacturing local, and that companies like Merck KGaA have partnered with local producers as a way of getting a foothold in the market.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Apple selfies spur diabetes donations

Jazz apples has launched a Crunch to Contribute campaign to raise money for one of two diabetes associations.

Baxter seeks Cambridge, Mass. HQ

Illinois may be tempted to offer tax incentives for the firm to stay put.

FDA wants Alexion to clean up

FDA inspectors have cited the manufacturer of the rare-disease drug Soliris (eculizumab) for poor manufacturing practices.